Dr Louise Schaper at PSA25[/caption]
Small towns, big challenges
With the launch of a new PSA report, pharmacists in regional and remote areas highlight disadvantages that access to more funding, collaboration and medication management reviews could improve.
Aspiration precautions for diabetes and weight-management therapies
Following several incident reports, the Therapeutic Goods Administration issued new precautions linked to these popular therapies.
How pharmacists can support patients through the PrEP shortage
The Therapeutic Goods Administration has announced shortages on several brands of HIV PrEP medicines, concerning healthcare professionals.
Dealing with aggressive customers? You’re not alone
As confirmed cases of COVID-19 in Australia tick over 4,700, many pharmacists face long working hours and the rising challenge of unacceptable customer behaviour.
A new way to discuss inhaler technique
By distinguishing between the two different types of inspiratory flow rates, this new label could help to improve inhaler technique.
TGA approves Symbicort prn to treat mild asthma
Symbicort prn is now indicated to treat mild asthma flare-ups after an extended indication was approved by the TGA.
Symbicort Turbuhaler and Rapihaler are now...
